Li Y, Chen L, Li L, Sottas C, Petrillo S, Lazaris A, et al. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. iScience. 2021;24:102457 pubmed publisher

Hu J, Zhu Z, Ying H, Yao J, Ma H, Li L, et al. Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice. Front Pharmacol. 2020;11:605065 pubmed publisher

Loyer X, Paradis V, Hénique C, Vion A, Colnot N, Guerin C, et al. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut. 2016;65:1882-1894 pubmed publisher

Ehrlich A, Ioannidis K, Nasar M, Abu Alkian I, Daskal Y, Atari N, et al. Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study. elife. 2023;12: pubmed publisher

Kim S, Lee I, Piao S, Nagar H, Choi S, Kim Y, et al. miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes. Commun Biol. 2022;5:1002 pubmed publisher

Brocker C, Kim D, Melia T, Karri K, Velenosi T, Takahashi S, et al. Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting. Nat Commun. 2020;11:5847 pubmed publisher

Wang Y, Yu T, Zhou Y, Wang S, Zhou X, Wang L, et al. Carnitine palmitoyltransferase 1C contributes to progressive cellular senescence. Aging (Albany NY). 2020;12:6733-6755 pubmed publisher